ReviewRSC advances2026
Research progress on immobilized penicillin G acylase and industrial applications.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immobilized penicillin G acylase (PGA) is a critical industrial biocatalyst for converting penicillin G into 6-aminopenicillanic acid (6-APA), a key intermediate in the synthesis of β-lactam antibiotics. Although various microorganisms can produce penicillin acylases, free PGA is highly susceptible to structural instability and environmental factors such as temperature and pH fluctuations, leading to a significant activity loss. Furthermore, the separation of free enzymes from reaction systems remains technically challenging, increasing operational complexity and cost. To overcome these limitations, immobilization strategies have been extensively explored. Immobilized PGA exhibits superior stability, reusability, and operational robustness, which are highly desirable for industrial applications. These advantages also lead to improved product purity, reduced contamination risks, and economic benefits. However, immobilization does not necessarily improve intrinsic catalytic efficiency, instead, it often involves a trade-off between catalytic activity and stability due to conformational constraints and mass transfer limitations. Although improved catalytic performance is sometimes reported, such enhancement generally reflects apparent activity rather than intrinsic catalytic efficiency. This review systematically summarizes the origins, classification, structure, and catalytic mechanisms of PGA. It also critically evaluates recent progress in immobilization methods, carrier materials, reaction media, enzyme activity regeneration, and reactor design, providing insights into future challenges and opportunities in this field.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.